[EN] TRIAZINE ANGIOGENESIS INHIBITORS<br/>[FR] INHIBITEURS D'ANGIOGENESE A BASE DE TRIAZINE
申请人:ABBOTT LABORATORIES
公开号:WO1999031088A1
公开(公告)日:1999-06-24
(EN) Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting angiogenesis in a mammal.(FR) L'invention concerne des composés de la formule (I) ou leurs sels ou promédicaments acceptables du point de vue pharmaceutique, ces composés s'utilisant dans le traitement d'états pathologiques découlant d'une angiogenèse ou exacerbés par une angiogenèse. L'invention concerne également des compositions pharmaceutiques contenant ces composés ainsi que des méthodes d'inhibition d'une angiogenèse chez un mammalien.
Iridium Supported on Phosphorus‐Doped Porous Organic Polymers: Active and Recyclable Catalyst for Acceptorless Dehydrogenation and Borrowing Hydrogen Reaction
作者:Wei Yao、Zheng‐Chao Duan、Yilin Zhang、Xinxin Sang、Xiao‐Feng Xia、Dawei Wang
DOI:10.1002/adsc.201900929
日期:2019.12.17
catalyst, which was thoroughly characterized by means of EDS, SEM, TEM, XRD, XPS, and FT‐IR, revealed excellent catalytic activity for the reaction of diphenyl phosphinamide with benzylalcohols through borrowinghydrogenstrategy and acceptorless dehydrogenation with wide functional group tolerance. Moreover, this POP−Ir catalyst could be simply recovered and reused for at least five times without a significant